Kumar Sunil, Anwer Razique, Azzi Arezki
Department of Biotechnology, Maharishi Markandeshwar (Deemed to Be University), Mullana, Ambala 133207, India.
Department of Pathology, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh 13317-4233, Saudi Arabia.
Microorganisms. 2021 Oct 6;9(10):2104. doi: 10.3390/microorganisms9102104.
is an opportunistic pathogen which is undoubtedly known for a high rate of morbidity and mortality in hospital-acquired infections. . causes life-threatening infections, including; ventilator-associated pneumonia (VAP), meningitis, bacteremia, and wound and urinary tract infections (UTI). In 2017, the World Health Organization listed as a priority-1 pathogen. The prevalence of infections and outbreaks emphasizes the direct need for the use of effective therapeutic agents for treating such infections. Available antimicrobials, such as; carbapenems, tigecycline, and colistins have insufficient effectiveness due to the appearance of multidrug-resistant strains, accentuating the need for alternative and novel therapeutic remedies. To understand and overcome this menace, the knowledge of recent discoveries on the virulence factors of is needed. Herein, we summarized the role of various virulence factors, including; outer membrane proteins, efflux pumps, biofilm, penicillin-binding proteins, and siderophores/iron acquisition systems. We reviewed the recent scientific literature on different virulence factors and the effective antimicrobial agents for the treatment and management of bacterial infections.
是一种机会致病菌,在医院获得性感染中无疑以高发病率和死亡率而闻名。它会引发危及生命的感染,包括呼吸机相关性肺炎(VAP)、脑膜炎、菌血症以及伤口和尿路感染(UTI)。2017年,世界卫生组织将其列为优先1级病原体。感染和暴发的流行凸显了直接需要使用有效的治疗药物来治疗此类感染。现有的抗菌药物,如碳青霉烯类、替加环素和黏菌素,由于多重耐药菌株的出现而有效性不足,这就更迫切需要替代的新型治疗方法。为了理解并克服这一威胁,需要了解关于其毒力因子的最新发现。在此,我们总结了各种毒力因子的作用,包括外膜蛋白、外排泵、生物膜、青霉素结合蛋白以及铁载体/铁获取系统。我们回顾了关于不同毒力因子以及治疗和管理细菌感染的有效抗菌药物的近期科学文献。